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rogress through mitosis is controlled by the sequential
destruction of key regulators including the mitotic
cyclins and securin, an inhibitor of anaphase whose
destruction is required for sister chromatid separation.
Here we have used live cell imaging to determine the exact
time when human securin is degraded in mitosis. We show
that the timing of securin destruction is set by the spindle
checkpoint; securin destruction begins at metaphase once
the checkpoint is satisﬁed. Furthermore, reimposing the
checkpoint rapidly inactivates securin destruction. Thus,
 
securin and cyclin B1 destruction have very similar
properties. Moreover, we ﬁnd that both cyclin B1 and
P
 
securin have to be degraded before sister chromatids can
separate. A mutant form of securin that lacks its destruction
box (D-box) is still degraded in mitosis, but now this is in
anaphase. This destruction requires a KEN box in the NH
 
2
 
terminus of securin and may indicate the time in mitosis
when ubiquitination switches from APC
 
Cdc20
 
 to APC
 
Cdh1
 
.
Lastly, a D-box mutant of securin that cannot be degraded
 
in metaphase inhibits sister chromatid separation, generating
 
a 
 
cut
 
 phenotype where one cell can inherit both copies of
the genome. Thus, defects in securin destruction alter
chromosome segregation and may be relevant to the develop-
ment of aneuploidy in cancer.
 
Introduction
 
The essential role of protein degradation in mitosis was first
inferred from the discovery of the mitotic cyclins that are de-
graded in each mitosis (Evans et al., 1983). Subsequently,
other key regulators have been identified whose destruction is
also required for progress through mitosis. Most prominent
amongst these is securin, an inhibitor of sister chromatid sep-
aration (Holloway et al., 1993; Cohen-Fix et al., 1996;
Funabiki et al., 1996b). Securin binds and inactivates sepa-
rase, a protease that cleaves the Scc1 cohesin subunit respon-
sible for sister chromatid cohesion (Cohen-Fix et al., 1996;
Ciosk et al., 1998; Uhlmann et al., 1999; Zou et al., 1999;
for review see Nasmyth et al., 2000; Uhlmann et al., 2000;
Waizenegger et al., 2000). Other proteins, such as Ase1 in
budding yeast, are required to stabilize the spindle and are
 
degraded late in mitosis (Juang et al., 1997). Thus, one key to
understanding mitosis is to determine how the right protein is
degraded at the right time. For example, it is clearly essential
that securin be degraded before Ase1 so that sister chromatids
will separate before the spindle disassembles.
Some of the important players that mediate mitosis-specific
proteolysis have been identified. These include the multi-
subunit anaphase promoting complex/cyclosome (APC/C)*
 
that acts as an ubiquitin ligase and the Cdc20/
 
fizzy
 
 and
Cdh1/
 
fizzy-related
 
 proteins that are required by the APC/C
to recognize its substrates (for reviews see Peters, 1998; Morgan,
1999; Zachariae and Nasmyth, 1999; Vodermaier, 2001).
 
APC/C
 
Cdc20
 
 and APC/C
 
Cdh1
 
 appear to have different substrate
specificities (Visintin et al., 1997). In vitro, APC/C
 
Cdc20
 
 rec-
ognizes proteins that contain a destruction box (D-box), a
loosely conserved nine amino acid motif with the consensus
 
RxxLxxxxN, whereas APC/C
 
Cdh1
 
 is able to recognize proteins
with either a D-box or a KEN box (Pfleger and Kirschner,
2000). Indeed, there are data to indicate that Cdc20 and
Cdh1 bind directly to proteins with these motifs (Burton
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and Solomon, 2001; Hilioti et al., 2001; Pfleger et al., 2001;
Schwab et al., 2001; for review see Vodermaier, 2001). Pro-
teolysis directed against cyclin B1 by APC/C
 
Cdc20
 
 is inhib-
ited by the spindle checkpoint, and this underlies the differ-
ence in the timing of cyclin A2 and cyclin B1 destruction in
mammalian cells (den Elzen and Pines, 2001; Geley et al.,
2001). In somatic cells, Cdc20 is replaced later in mitosis by
Cdh1 (Schwab et al., 1997; Sigrist and Lehner, 1997; Visintin
et al., 1997; Fang et al., 1998; Kramer et al., 1998), but the
exact time at which this occurs in mammalian cells has not
been established. Current thinking based on evidence from
budding yeast is that Cdh1 has to be dephosphorylated be-
fore it can bind to the APC/C and that this can only happen
once the mitotic cyclin/cyclin-dependent kinases (CDKs)
have been inactivated (Visintin et al., 1998; Zachariae et al.,
1998; Jaspersen et al., 1999; for reviews see Morgan, 1999
and Zachariae and Nasmyth, 1999; Kramer et al., 2000).
Much of our understanding of when and how mitotic reg-
ulators are degraded in mitosis has come from studies using
budding and fission yeast and from early embryonic systems
such as 
 
Xenopus
 
 and 
 
Drosophila.
 
 In budding yeast, securin
(Pds1p) is important but not essential for the proper timing
of sister chromatid separation (Cohen-Fix et al., 1996;
Yamamoto et al., 1996; Ciosk et al., 1998; Shirayama et al.,
1999). Pds1p also has an important role to play in the re-
sponse to DNA damage (Cohen-Fix and Koshland, 1999;
Gardner et al., 1999; Sanchez et al., 1999; Tinker-Kulberg
and Morgan, 1999; Wang et al., 2001). The stability of
Pds1p is regulated by the Mec1p-dependent DNA damage
response pathway, and a nondegradable Pds1p will arrest
yeast cells in mitosis (Clarke et al., 1999; Gardner et al.,
1999; Sanchez et al., 1999; Wang et al., 2001). In contrast,
fission yeast with a nondegradable securin proceed with cy-
tokinesis even though they are unable to separate their sister
chromatids, resulting in a 
 
cut
 
 (chromosomes untimely torn)
phenotype (Funabiki et al., 1996b). Hence fission yeast se-
curin is called cut2. Both Pds1p and cut2 bind and inhibit
separase to prevent sister chromatid separation, but both are
also required for the proper functioning of the separase
(Funabiki et al., 1996a; Uhlmann et al., 1999; Jensen et al.,
2001). For example, fission yeast cut2 is required to load
separase (cut1) onto the mitotic spindle. In 
 
Drosophila
 
, se-
curin is the product of the 
 
pimples
 
 gene (Stratmann and Leh-
ner, 1996; Leismann et al., 2000; Jager et al., 2001). A non-
degradable pimples protein also causes a 
 
cut
 
 phenotype but
only at high levels; at low levels, nondegradable pimples will
rescue a 
 
pimples
 
 mutant (Leismann et al., 2000)
 
.
 
Human securin (hsecurin) was identified as the product of
the pituitary tumor transforming gene and shown to bind to
human separase (Zou et al., 1999). Human securin, like
Pds1p, cut2, and pimples, is required not only to inhibit the
separase but also to generate the active form of the separase
in an as yet unexplained manner (Jallepalli et al., 2001).
Thus, a cell line without hsecurin does not prematurely sep-
arate its sister chromatids. Rather, it exhibits high chromo-
some loss and abnormal anaphases because of a reduction in
the level of active separase (Jallepalli et al., 2001). Mice with
a homozygous deletion for securin have also been reported,
and these have developed into apparently normal 4-wk-old
animals. However, in culture the embryonic fibroblasts from
 
these animals spend more time in G2 phase and in mitosis
(Mei et al., 2001).
Human securin can be ubiquitinated in vitro by both
APC/C
 
Cdc20
 
 and APC/C
 
Cdh1
 
, and both a D-box and a KEN
box have to be mutated to generate a nondegradable protein
(Zur and Brandeis, 2001). Nondegradable hsecurin also
causes a 
 
cut
 
 phenotype in which some chromatin is trapped
in the cleavage furrow in a minority of cells, although the
majority of the sister chromatids separate (Zur and Brandeis,
2001). However, it is still unknown when securin degrada-
tion is initiated in mitosis and how this relates to the de-
struction of other mitotic regulators, such as cyclin A2 and
cyclin B1, and to the spindle checkpoint. Thus, we have an-
alyzed securin degradation in living cells and find that its de-
struction resembles that of cyclin B1, being initiated at the
beginning of metaphase well before sister chromatid separa-
tion. Furthermore, at least at high levels, cyclin B1–CDK1
can block anaphase, indicating that both securin and cyclin
B1 must be degraded to allow sister chromatid separation.
We also show that a securin with a mutant D-box but an in-
tact KEN box is degraded later in mitosis, possibly indicat-
ing the time at which ubiquitination switches from media-
tion by APC/C
 
Cdc20
 
 to APC/C
 
Cdh1
 
. Lastly, we find that a
nondegradable securin can cause all the sister chromatids to
be inherited by one cell.
 
Results
 
Securin–fluorescent proteins are valid markers 
for endogenous securin
 
We established an in vivo assay for proteolysis using green
fluorescent protein (GFP) fusion proteins (Clute and
Pines, 1999; den Elzen and Pines, 2001). Because the level
of GFP fluorescence was directly related to the amount of
GFP fusion protein, we were able to follow proteolysis in
real time by the decrease in GFP fluorescence. With this
assay, we showed that cyclin A2 began to be degraded at,
or just after, nuclear envelope breakdown, whereas cyclin
B1 destruction began later, when the spindle checkpoint
had been satisfied (i.e., when all the chromosomes were at-
tached to both poles of the mitotic spindle) (Clute and
Pines, 1999; den Elzen and Pines, 2001). To determine
when securin destruction began in relation to cyclins A and
B1, we tagged securin at the COOH terminus with cyan
fluorescent protein (CFP), GFP, or yellow fluorescent pro-
tein (YFP). We were able to validate the securin–fluores-
cent proteins (FPs) as markers for endogenous securin by
the following criteria. First, securin and the securin–FP
chimaeras had the same localization pattern in interphase
(unpublished data) and mitosis (Fig. 1 A). In interphase,
the proteins were primarily nuclear, and in mitosis both se-
curin and securin–YFP were localized throughout the cell
and on the spindle but not on the chromosomes. Second,
securin and the securin–FPs both bound to human sepa-
rase (Fig. 1 B). Third, nondegradable versions of securin
and securin–YFP gave identical phenotypes in mitosis, pre-
venting chromosome separation (see below). Lastly, in fis-
sion yeast a securin (cut2)–GFP fusion protein had been
shown to rescue a 
 
cut2
 
 temperature-sensitive mutant (Ku-
mada et al., 1998). 
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Securin–FP degradation is controlled by the 
spindle checkpoint
 
We injected cells with securin–FP constructs and assayed
their progress through mitosis by time-lapse fluorescence
and DIC microscopy (see Materials and methods). This
showed that low to moderate levels of securin–FP made no
significant difference to the length of any phase of mitosis,
although high levels of securin–FP did extend metaphase
(Fig. 2 A). Securin–FP fluorescence gradually increased
through interphase and consistently began to fall just before
all of the chromosomes aligned on the metaphase plate (Fig.
2 B). This indicated that securin might only have been rec-
ognized as a substrate for ubiquitination after the spindle
checkpoint was satisfied. Consistent with this, disrupting
proper spindle assembly by treating cells with nocodazole or
taxol prevented securin–FP destruction (unpublished data),
and spindle poisons were able to stop securin degradation
even after it had begun (Fig. 2 C). Securin degradation was
also blocked by the 26S proteasome inhibitor MG132,
demonstrating that it was proteasome dependent (Fig. 2 D).
In all of these properties, securin degradation strongly re-
sembled that of cyclin B1 (Clute and Pines, 1999), and by
quantifying the fluorescence levels of cyclin B1–CFP and se-
curin–YFP expressed in the same cell we found their degra-
dation consistently began at the same time (Fig. 2 E). How-
ever, cyclin B1 and securin only partially colocalized on the
mitotic apparatus (Fig. 2 G).
We and others showed that the difference in the timing of
cyclin A2 and cyclin B destruction in mammalian cells was
imposed by the spindle checkpoint in prometaphase (den
Elzen and Pines, 2001; Geley et al., 2001). Cyclin A2 degra-
dation was insensitive to the spindle checkpoint and began
as soon as the nuclear envelope broke down, whereas cyclin
B1 was only degraded once the spindle checkpoint was inac-
tivated. Furthermore, disrupting the spindle checkpoint ma-
chinery with a dominant negative version of Bub1 caused
cyclin B1 to be degraded prematurely in prometaphase (Ge-
ley et al., 2001). To determine whether this also applied to
securin degradation, we coinjected securin–FP with a domi-
nant negative mutant of Bub1 to disrupt the checkpoint.
This showed that in the absence of the spindle checkpoint
securin was degraded at the same time as cyclin A2, as soon
as the nuclear envelope broke down (Fig. 2 F).
 
Securin degradation may not be sufficient for anaphase
 
Introducing a dominant negative Bub1 mutant caused securin
to be degraded prematurely, and cells rapidly began anaphase,
but this did not show that securin degradation alone could
cause sister chromatid separation because eliminating the
spindle checkpoint would advance the degradation of other
mitotic regulators, such as cyclin B1 (Geley et al., 2001). To
determine the requirements for sister chromatid separation in
mammalian cells, we coexpressed a dominant negative mutant
of Bub1 with a nondegradable version of cyclin B1 and as-
sayed sister chromatid separation by both DIC microscopy
and by fixing and staining cells with anticentromere or anti–
phospho-histone H3 antibodies. To analyze the behavior of
all of the sister chromatids, we used PtK1 cells that only have
12 sets of chromosomes. In some experiments, we expressed a
nondegradable cyclin B1 alone and analyzed cells after all of
the securin should have been degraded (at least 1 h after
metaphase began; on average, control PtK1 cells enter ana-
phase 23 min after chromosome alignment [Rieder et al.,
1994]). We found that whether sister chromatids separated in
the absence of securin depended on the level of cyclin B1.
With low levels of cyclin B1, sister chromatids could separate
(Fig. 3 A), but cells arrested in late anaphase as described pre-
viously (Wheatley et al., 1997); however, at moderate to high
levels of cyclin B1 sister chromatids remained together for sev-
eral hours after the disappearance of securin (Fig. 3, B and C).
Figure 1. Securin–YFP is an appropriate marker for endogenous 
securin. (A) HeLa cells were microinjected in the nucleus with an 
expression construct for securin (left) or securin linked to YFP (right). 
After 3 h, the cells were fixed, and cells injected with the untagged 
securin were stained with antisecurin antibodies. Cells were analyzed 
by confocal fluorescence microscopy. A single z section is shown 
for each cell. (B) HeLa cells were transfected with an expression 
construct for securin tagged with a myc epitope (lanes 1 and 2) or 
an expression construct for securin–myc linked to YFP (lanes 3 and 4). 
Cells were arrested with nocodazole, and cell extracts were prepared 
and used to immunoprecipitate separase (S). An unrelated antibody 
was used as a control for immunoprecipitation (C). The precipitates 
were immunoblotted with specific antibodies against hseparase 
(top), hsecurin (middle), and YFP (bottom). Arrows indicate tagged 
forms of hsecurin; the arrowhead points to endogenous securin. 
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Figure 2.
 
Securin is degraded in metaphase coincident with cyclin B1, and its proteolysis is controlled by the spindle checkpoint. 
 
(A) High 
levels of securin–FP extend metaphase. HeLa cells synchronized in late G2 phase were microinjected with an expression construct for 
securin–FP and followed by time-lapse fluorescence microscopy at 3-min intervals. The length of metaphase was determined and plotted 
against the level of securin–FP fluorescence at the beginning of metaphase. We defined metaphase as either the time between chromosome 
alignment and sister chromatid separation, or, in cells exhibiting chromosome nondisjunction, the time between chromosome alignment and 
cell elongation. The length of metaphase in uninjected cells was 9.9 
 
 
 
 9.6 min (den Elzen and Pines, 2001). The dashed line indicates the 
maximum length of metaphase in control uninjected cells. (B) Securin degradation starts at metaphase. HeLa cells synchronized in late G2 
phase were microinjected in the nucleus with an expression construct for securin–YFP and followed by time-lapse fluorescence and DIC 
microscopy at 3-min intervals. The total cell fluorescence minus background was quantified for each cell in successive images of a time  
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(We found that nondegradable cyclin B1 did not affect the
degradation of securin [see Fig. 7 B; unpublished data]). We
have shown previously that when expressed at moderate levels
ectopic cyclin B1, or cyclin A2, is present at 
 
 
 
50–100% of
the level of the endogenous cyclin (Draviam et al., 2001; den
Elzen and Pines, 2001). Thus, we estimate that a 1.5–2-fold
overexpression of cyclin B1 is sufficient to block sister chroma-
tid separation in the absence of securin. Although it is not
clear whether cyclin B1 would ever normally reach these levels
 
in vivo, our observations agree with the results of Stemmann
et al. (2001) who found that a twofold excess of cyclin
B1 blocked sister chromatid separation in 
 
Xenopus
 
 extracts
through phosphorylating and inactivating separase.
 
Nondegradable securin can cause complete 
chromosome nondisjunction
 
We wished to determine whether securin linked karyokinesis
with cytokinesis in human cells. In budding yeast, nondegrad-
 
series and plotted over time. The degradation profile of a single cell, representative of 10 cells analyzed, is shown. The stages of mitosis are 
indicated at the bottom of the figure. (C and D) Securin degradation is proteasome- and spindle checkpoint–dependent. HeLa cells were 
injected and analyzed as described in A. To reimpose the checkpoint or to stop proteasome-dependent degradation, cells in metaphase were 
treated with 10 
 
 
 
M taxol (C) or 100 
 
 
 
M MG132 (D), respectively. The arrow indicates the point at which taxol or MG132 was added, and the 
arrowhead indicates the start of metaphase. Graphs are of single cells, representative of at least four cells analyzed for each chemical. (E) Securin 
degradation coincides with cyclin B1 destruction. HeLa cells synchronized in late G2 phase were coinjected with cDNAs encoding cyclin 
B1–CFP and securin–YFP. Cells were analyzed as in A. The degradation profile of a single cell, representative of at least five cells analyzed, 
is shown. (F) In the absence of the spindle checkpoint, securin degradation starts in prometaphase. HeLa cells were synchronized in late G2 
phase and coinjected with cDNAs encoding securin–YFP and a dominant negative mutant of Bub1. Cells were followed by time-lapse microscopy 
and analyzed as in A. The times of the completion of nuclear envelope breakdown and the start of chromosome segregation are indicated. 
The degradation profile of a single cell, representative of at least four cells analyzed, is shown. (G) Cyclin B1 and securin do not exactly 
colocalize. HeLa cells were coinjected with cDNAs encoding cyclin B1–YFP and securin–CFP, and fluorescence and DIC pictures were 
taken at the beginning of metaphase.
 
Table I. 
 
Characterization of the effect of securin expression
Securin 
construct
Coexpressed 
with
Expression
level
Number of 
cells 
injected
Number of 
cells
with normal
anaphase
Number of 
cells
with cut
phenotype
Cells with 
cut 
phenotype
Number of
cells with all
chromosomes
moving to one 
pole
 
%
 
Wild-type YFP 8 7 1 12.5 1
 
 
 
D-box YFP 5 0 5 100 4
Wild-type–YFP low 11 8 3 27 0
high 14 2 12 86 10
 
 
 
D-box–YFP low 8 0 8 100 4
high 10 0 10 100 6
R61A–YFP low 3 0 3 100 0
high 2 0 2 100 2
KEN box mutant–YFP low 6 5 1 16 1
high 3 0 3 100 1
 
 
 
D-box/KEN box double mutant–YFP low 3 0 3 100 0
Wild-type–YFP Cyclin B1–CFP 7 5 2 28 1
 
 
 
D-box–YFP Cyclin B1–CFP 6 0 6 100 3
KEN box mutant–YFP Cyclin B1–CFP 2 1 1 50 0
 
 
 
D-box/KEN box double mutant–YFP Cyclin B1–CFP 5 0 5 100 4
Wild-type–YFP Securin 
 
 
 
D-box–CFP 5 0 5 100 0
 
 
 
D-box/KEN box double mutant–YFP Securin 
 
 
 
D-box–CFP 5 0 5 100 2
HeLa cells synchronized in late G2 phase were injected with securin expression constructs, with or without cyclin B1 constructs, and followed by time-lapse
fluorescence and DIC microscopy. The total fluorescence per cell was quantified and categorized as either low (
 
 
 
2,000,000 pixels for YFP) or high (
 
 
 
2,000,000 pixels
for YFP). Cells coexpressing securin constructs with high levels of cyclin B1 that arrested in metaphase were not included in this analysis. NB, A cut phenotype was
never seen in control uninjected cells. 
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Figure 3. Cyclin B1 levels can affect sister chromatid separation. (A) Low levels of cyclin B1 at the end of metaphase cause a late anaphase 
arrest. PtK1 cells were injected with an expression construct for nondegradable cyclin B1–GFP (R
42A mutation). Cells expressing low levels of 
R
42A–cyclin B1–GFP ( 10
6 pixels for GFP) were followed by time-lapse fluorescence and DIC microscopy at 3-min intervals. The cell shown 
is representative of more than four cells analyzed. (B and C) High levels of cyclin B1 at the end of metaphase prevent sister chromatid separation. 
PtK1 cells were injected with an expression construct for nondegradable cyclin B1–GFP as in A. Cells expressing moderate to high levels of 
R
42A–cyclin B1–GFP ( 10
6 pixels for GFP) were followed by time-lapse fluorescence and DIC microscopy at 3-min intervals. Once cells had 
been in metaphase for  1 h, they were fixed and stained with anti-CREST (B) or anti-CREST and phospho-histone H3 antibodies (C). Cells 
were analyzed by confocal laser scanning microscopy, and either a single z section (B) or a projection of several z sections is shown (B and C). 
The arrows in B indicate pairs of kinetochores. In the single z section, only one kinetochore of the pair is visible, and the chromosomes can be 
visualized by the negative stain for cyclin B. The cell shown is representative of more than four cells analyzed. The arrows in Fig. 3 C indicate 
unseparated sister chromatids. The cell shown is representative of more than three cells analyzed. 
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able Pds1p arrested cells in metaphase, whereas in fission yeast
nondegradable cut2 prevented sister chromatid separation but
could not prevent cytokinesis. The reported effect of a non-
degradable human securin was ambiguous: nondegradable
hsecurin only induced a mild 
 
cut
 
 phenotype where a small
amount of chromatin was trapped between the two daughter
cells, and this was in only a minority (5%) of human cells
(Zur and Brandeis, 2001). To explore the requirement for se-
curin degradation in human cells, we made several mutations
in the putative destruction motifs of hsecurin (Fig. 4 A). Ini-
tially, we made a point mutation in a conserved residue of the
putative D-box or deleted the D-box altogether. When intro-
duced into cells, both of these securin mutants failed to be de-
graded in metaphase (but were degraded later in mitosis [Fig.
4 E and see Fig. 6 B]) and caused a dramatic 
 
cut
 
 phenotype in
100% of the injected cells. This phenotype was observed with
nondegradable securins with or without a GFP tag and rou-
tinely with high levels of wild-type securin–FP (Table I). In
cells exhibiting a 
 
cut
 
 phenotype, all of the observable sister
chromatids failed to separate before anaphase B and either re-
mained in the center of the cell to be disrupted by the cyto-
kinesis furrow (Fig. 4 B) or moved to one spindle pole to be
inherited by one cell (Fig. 4 C). (We took cell elongation to be
indicative of anaphase B.) Neither of these 
 
cut
 
 phenotypes ap-
peared to be more severe than the other because there was no
obvious correlation between the phenotype observed and the
level of securin expressed (Table I).
In those cells where all of the chromosomes moved to one
pole, the sister chromatids occasionally separated in one half of a
cell, reversing the normal sequence of anaphase A and B. Fur-
thermore, in some of these cells a second cleavage furrow initi-
ated between the separating chromatids (Fig. 4 D). Further ob-
servations showed that a cell that apparently failed to inherit
chromosomes continued to bleb after cytokinesis and eventually
either fused with the other daughter cells or died. The cell that
inherited all of the chromosomes eventually reentered inter-
phase. The daughter cells formed by either 
 
cut
 
 phenotype usu-
ally took a long time to reform their nuclear envelopes and often
failed completely to separate. This was likely to be caused by
chromatin that was trapped in the cleavage furrow, visualized by
staining with Hoechst 33342 (unpublished data) as described
previously (Mullins and Biesele, 1977; Hauf et al., 2001).
Based on our present understanding of mitosis, these 
 
cut
 
phenotypes were indicative of cells in which securin was still
present, preventing chromatid separation, but cyclin B1 had
been degraded, enabling cytokinesis to occur. In agreement
 
Figure 4.
 
Nondegradable securin causes a 
 
cut
 
 phenotype.
 
 (A) 
Schematic diagram of securin constructs. The D-box (R
 
61
 
-N
 
68
 
) and 
KEN box (K
 
9
 
-N
 
11
 
) are indicated. (B and C) HeLa cells injected with 
an expression vector encoding a securin D-box deletion mutant–YFP 
fusion protein were followed through mitosis by time-lapse 
microscopy, and DIC pictures were taken every three min. These 
cells are representative of at least 18 cells analyzed. (D) Reversion 
of the sequence of anaphase A and B. HeLa cells were coinjected 
with cDNAs expressing cyclin B1–CFP and a securin D-box deletion 
mutant–YFP (top) or with cDNAs expressing securin D-box mutant–
CFP and a securin D-box/KEN box double mutant–YFP (bottom). 
Cells were followed through mitosis by time-lapse microscopy, and 
DIC pictures were taken every three min. In a minority of cells, the 
sister chromatids separated after the cell elongated. (E) HeLa cells 
were coinjected with cDNAs expressing cyclin B1–CFP and a 
securin D-box deletion mutant–YFP. Cells were followed by time-
lapse microscopy. Fluorescence and DIC pictures were taken at 
3-min intervals and analyzed as described in the legend to Fig 2. 
The degradation profile of a single cell is shown and is representative 
of at least six cells analyzed. The times at which metaphase and 
anaphase B started are shown. 
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Figure 5. Securin can be ubiquitinated by APC/
C
Cdc20 and APC/C
Cdh1. (A) APC/C
cdh1 can ubiquitinate 
securin and securin–YFP with equal efficiency in 
vitro. (B) In vitro ubiquitination of securin–YFP by 
APC/C
CDC20 is dependent on an intact D-box. (C) 
APC/C
CDH1 ubiquitinates securin–YFP containing 
either an intact D-box or KEN box. In A–C, APC/C 
was immunoprecipitated from Xenopus egg extracts 
and activated with recombinant CDH1 or CDC20. 
35S-labeled in vitro–translated securin or securin–YFP 
wild-type (wt), D-box mutant ( DB), KEN box 
mutant ( KB), or D-box/KEN box double mutants 
were used as substrates. (D and E) Quantification 
of the data shown in B and C. The amount of 
securin–YFP conjugated to ubiquitin is shown as the percent of the total amount of securin–YFP per reaction. Time points 0 (hatched bars) 
and 30 min (black bars) indicate, respectively, the start and end points of the reaction.
 
with this interpretation, nondegradable securin did not af-
fect cyclin B1 degradation (Fig. 4 E).
 
Securin mutants may reveal when Cdh1 replaces 
Cdc20 in mitosis
 
Currently, APC/C
 
Cdc20
 
 is thought to ubiquitinate proteins
with a D-box, whereas APC/C
 
Cdh1
 
 that is active later in mi-
tosis is thought to recognize proteins with either a D-box or
a KEN box (Pfleger and Kirschner, 2000). Thus, we consid-
ered that we might be able to use securin mutants to analyze
when proteolysis switches from mediation by Cdc20 to
Cdh1. Therefore, in addition to the D-box mutants we
made hsecurin mutants in which we eliminated the KEN
box by replacing the residues KEN with AAA.
Figure 6. Securin destruction in metaphase requires only the D-box not the KEN box. (A) Degradation of the securin KEN box mutant 
starts at metaphase. HeLa cells were injected with an expression vector for a securin KEN box mutant–YFP fusion protein and followed 
through mitosis by time-lapse microscopy. Fluorescence and DIC pictures were taken at 3-min intervals and analyzed as described in the 
legend to Fig 2. The times of the beginning of metaphase and chromosome segregation are indicated. The graph is representative of at least 
five cells analyzed. (B) HeLa cells were coinjected with cDNAs encoding a securin D-box deletion mutant–CFP and the securin wildtype–
YFP fusion proteins. The cells were analyzed as described in the legend to Fig. 2. The times at which metaphase and anaphase B started are 
indicated. The degradation profile of a single cell is shown and is representative of at least five cells analyzed. All cells had a cut phenotype. 
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First, we tested which APC/C complexes were able to ubiq-
uitinate the different securin mutants in vitro. We found that
APC/C
 
Cdc20
 
 and APC/C
 
Cdh1
 
 complexes were able to ubiquiti-
nate securin or securin–FP constructs with equal efficiency
(Fig. 5 A; unpublished data). In accordance with the prevailing
view, we found that APC/C
 
Cdc20
 
 was only able efficiently to
ubiquitinate securin or securin–FP that possessed a wild-type
D-box, and it did not matter whether or not the mutant had a
KEN box (Fig. 5, B and D). In contrast, APC/C
 
Cdh1
 
 ubiquiti-
nated securin with either a wild-type D-box or a KEN box
(Fig. 5, C and E) but was unable efficiently to ubiquitinate a
protein lacking both destruction motifs (Fig. 5, C and E).
When assayed in vivo, the KEN box mutant was degraded
in metaphase at the same time as the wild-type protein, the
sister chromatids separated on time and the cells exited mi-
tosis normally (Fig. 6 A). (At high levels, this mutant also
caused a 
 
cut
 
 phenotype in a similar manner to the wild-type
protein [Table I].) This showed that the KEN box was dis-
pensable for degradation in metaphase and apparently for
mitosis. However, because we did not follow cells for a sec-
ond cell cycle we do not know whether a mutation in the
KEN box would give a phenotype in interphase or the next
mitosis. As mentioned above, the D-box mutant caused a 
 
cut
 
phenotype because it was not degraded in metaphase. How-
Figure 7. The degradation profile of a securin mutant dependent on a KEN box for destruction reveals when Cdh1 replaces Cdc20. (A) The 
securin D-box mutant is degraded in anaphase, and a D-box/KEN double box mutant is partially stabilized in mitosis. HeLa cells were coinjected 
with cDNAs encoding a securin D-box deletion mutant linked to CFP and a securin D-box/KEN box double mutant linked to YFP. Cells were 
followed through mitosis, and DIC and fluorescence pictures were taken at 3-min intervals and analyzed as in the legend to Fig 2. The times 
at which metaphase and anaphase B started are indicated. The graph of a single cell is shown and represents at least eight cells analyzed. 
(B) Coexpressing cyclin B1 enhances the degradation of the securin double mutant. HeLa cells were coinjected with expression constructs for 
a wild-type cyclin B1–CFP together with a securin D-box and KEN box double mutant linked to YFP. Cells were followed, and DIC and 
fluorescence pictures were taken every 3 min and analyzed as in the legend to Fig 2. The times at which metaphase and anaphase B started 
are indicated. The graph of a single cell is shown and represents at least five cells analyzed. (C) High cyclin B1/CDK1 activity prevents the 
degradation of a securin mutant that depends on a KEN box for its proteolysis. HeLa cells were coinjected with expression constructs for a 
nondegradable R
42A–cyclin B1–CFP together with either securin–YFP (left) or a securin D-box mutant linked to YFP (right). Cells were followed, 
and DIC and fluorescence pictures were taken every 3 min and analyzed as in the legend to Fig 2. The times at which metaphase started are 
indicated. The graph of a single cell is shown and represents at least five cells analyzed for each securin mutant. 
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ever, just before the cell began to elongate, indicative of ana-
phase B, this mutant was degraded (Fig. 6 B).
One interpretation of these results was that proteolysis
switched from mediation by APC/C
Cdc20 to APC/C
Cdh1 in
anaphase, and at this point the D-box mutant could be de-
graded via its KEN box. To test this, we analyzed the degra-
dation of a securin mutant that lacked both a D-box and a
KEN box. We found that in most cells this protein was
more stable than either the D-box or the KEN box mutants
(Fig. 7 A). However, the double mutant was not completely
stable after anaphase, indicating that there may be other mo-
tifs that target it for degradation (Fig. 7 A). As expected, this
mutant blocked sister chromatid (giving cut phenotypes like
those induced by the single D-box mutant) but had no effect
on cyclin B1 degradation or cytokinesis. Interestingly, we
found that coexpressing cyclin B1 with this mutant ap-
peared to increase the efficiency with which the securin mu-
tant was eventually degraded (Fig. 7 B).
Previous studies provided evidence that B-type cyclin–
CDK activity inhibited APC
Cdh1-mediated proteolysis by
phosphorylating Cdh1 (Zachariae et al., 1998; Jaspersen et
al., 1999; Kramer et al., 2000). Thus, if APC
Cdh1 did medi-
ate degradation of the D-box securin mutant this should
have correlated with reduced cyclin B1–CDK activity. Con-
sistent with this prediction, we found that D-box mutants
began to be degraded at the time when the majority of cyclin
B1–FP had been degraded (Fig. 4 E and Fig. 7 B). Further-
more, when we coexpressed the D-box mutant of securin
with nondegradable cyclin B1 to maintain Cdh1 in its inac-
tive (phosphorylated) form the mutant securin was now
completely stable (Fig. 7 C).
Discussion
In this paper, we have studied the degradation of securin in
dividing human cells. We have used securin FPs to follow
the localization and proteolysis of securin in real time. A pre-
vious study using a securin–GFP fusion protein in living
cells found that securin–GFP transfected into endothelial
cells, inhibited mitosis, and promoted apoptosis (Yu et al.,
2000). In those few cells that entered mitosis the protein was
judged to disappear in anaphase, but this was based on a
qualitative assessment of fluorescence. In contrast, we find
that securin–GFP neither induces apoptosis nor inhibits en-
try into mitosis. Furthermore, we have quantified the disap-
pearance of securin–FP and shown that its degradation be-
gins at metaphase. The differences between our results and
the previous study may lie in the cell type used or reflect an
advantage of microinjection over transfection.
We have shown that the timing of securin destruction is
controlled by the spindle checkpoint; destruction only
begins at metaphase, and reimposing the checkpoint in
metaphase rapidly inactivates securin proteolysis. Further-
more, disrupting the checkpoint machinery with a domi-
nant negative mutant of Bub1 causes securin to be degraded
prematurely, just after nuclear envelope breakdown. Thus,
the properties of securin destruction resemble those of cyclin
B1. However, securin and cyclin B1 do not have identical
subcellular localization patterns in mitosis; unlike cyclin B1,
securin does not stain the chromosomes in prometaphase.
Therefore, if as suggested previously there is some spatial
control on ubiquitination in mitosis (Clute and Pines, 1999;
Huang and Raff, 1999) this might be able to discriminate
between cyclin B1 and securin, although we have not yet
found conditions that uncouple securin from cyclin B1 de-
struction. This is in contrast to budding yeast where securin
(Pds1p) and a fraction of the major B-type cyclin, Clb2, are
degraded before anaphase, but a significant proportion of
Clb2 remains to be degraded later in mitosis (Lim et al.,
1998; Baumer et al., 2000; Yeong et al., 2000).
Although securin destruction begins as soon as the spindle
checkpoint is inactivated, sister chromatids often do not sep-
arate until much later ( 23 min later in PtK1 cells [Rieder
et al., 1994]). Moreover, at anaphase all of the sister chro-
matids separate with a high degree of synchrony. It is diffi-
cult to reconcile this observation with a model in which
sister chromatid separation is solely controlled by the ac-
tivation of separase after securin is destroyed. If this is the
case, then active separase could accumulate for  20 min be-
fore sister chromatid disjunction, and it is unlikely that all of
the sister chromatids would separate at the same time. Fur-
thermore, the majority of securin
 /  mouse cells must also
separate their chromosomes correctly as evidenced by their
ability to proliferate in culture (Jallepalli et al., 2001) and to
generate apparently normal animals (Mei et al., 2001).
Thus, we favor a model in which there is a second step to sis-
ter chromatid separation, perhaps related to the recent dem-
onstration that the budding yeast separase is only able to rec-
ognize the phosphorylated form of its cohesin substrate
(Alexandru et al., 2001). In some cells injected with securin–
FP we observe a cut phenotype even after the securin–GFP
has fallen below detectable levels. This may be because there
is still sufficient securin to inactivate the separase. However,
the more interesting possibility is that there is insufficient
time for the second step between securin destruction and the
cleavage of cohesin.
The second step to sister chromatid separation may involve
the inactivation of cyclin B1–CDK1. We find that moderate
to high amounts of cyclin B1 (Fig. 3) will prevent sister chro-
matid separation in the absence of securin, and we have
shown previously that cyclin A2 must also be degraded to al-
low anaphase (den Elzen and Pines, 2001). High amounts of
cyclin B–CDK1 activity have been shown to prevent sister
chromatid separation in Xenopus extracts because separase re-
mains phosphorylated and its ability to cleave cohesin in vitro
is significantly reduced (Stemmann et al. 2001). Thus, it ap-
pears that cyclin B1–CDK1, and possibly cyclin A2–CDKs,
may directly or indirectly inactivate separase. This alternative
means of regulating sister chromatid separation could explain
why securin is not an essential protein in mammalian cells
(Jallepalli et al., 2001; Mei et al., 2001).
Securin degradation is a key event in mitosis. We found
that all of the securin mutants that could not be degraded in
metaphase block sister chromatid separation, and unlike bud-
ding yeast human cells do not have a mechanism to prevent
cytokinesis in this event. Thus, the daughter cells inherit an
incorrect complement of chromosomes, and this may be the
mechanism by which overexpressed human securin trans-
forms 3T3 cells (Pei and Melmed, 1997). This emphasizes the
importance of the spindle checkpoint both to normal progres- Metaphase destruction of securin | Hagting et al. 1135
sion through mammalian mitosis and for genomic stability.
This is underscored by the observations that mice lacking
spindle checkpoint components such as Mad2 (Dobles et al.,
2000) and Bub3 (Kalitsis et al., 2000) die early in embryogen-
esis with gross mitotic abnormalities. Furthermore, a haplo in-
sufficiency of Mad2 gives rise to chromosomal instability and
eventually to tumorigenesis (Michel et al., 2001) so the level
of the checkpoint proteins is likely to be crucial to the proper
regulation of securin and cyclin B1 destruction.
Because all of the cells expressing securin mutants that
could not be degraded in metaphase exhibit a cut phenotype,
we conclude that degrading human securin is an essential
prerequisite for sister chromatid separation. However, the
phenotype we observed for the D-box mutant of securin dif-
fers from the cut phenotype observed by Zur and Brandeis
(2001) in which only a small minority (5%) of HeLa cells
expressing a nondegradable securin failed to complete cyto-
kinesis and remained connected by chromatin threads. The
difference may be due to the different experimental ap-
proaches; we microinjected cells and followed them by time-
lapse microscopy, whereas Zur and Brandeis (2001) trans-
fected cells and analyzed them after fixation.
The high rates of whole chromosome loss that we observe
for cells with nondegradable securin are similar to the effects
of the loss of securin in human cells (Jallepalli et al., 2001).
This might appear paradoxical but can be explained by data
indicating that securin is required fully to activate separase
(Jallepalli et al., 2001). Thus, a nondegradable separase in-
hibitor would have the same effect as an inability to activate
separase. Cells without securin also exhibit problems with
sister chromatid separation, but these problems are only seen
in about a third of the population, perhaps because the cells
still have a low but detectable level of active separase.
The behavior of the various securin mutants in mitosis
may give some clues to the changes in the machinery under-
lying progression through mitosis in somatic cells. A securin
mutant with a defective D-box but an intact KEN box could
be ubiquitinated by APC/C
Cdh1 but not APC/C
Cdc20 in vitro.
Although this is an artificial substrate (because normally all
the securin should be degraded in metaphase by APC/
C
Cdc20) in vivo this mutant was stable throughout metaphase
but became unstable just before the cell began to elongate at
anaphase B. Thus, the switch from APC/C
Cdc20- to APC/
C
Cdh1-dependent destruction appears to happen in anaphase.
By extrapolation from results obtained with budding yeast,
this could be explained by the disappearance of cyclin B1–
CDK activity at the end of metaphase leading to the dephos-
phorylation of Cdh1. Dephosphorylated Cdh1 would then
bind the APC (Kramer et al., 2000) and begin the degrada-
tion of Cdc20 and other KEN box substrates. In support of
this model, we find that a nondegradable cyclin B1 mutant
prevents the destruction of the securin D-box mutant with
an intact KEN box. Alternatively, but less likely, APC/C
Cdc20
might alter its specificity to recognize the KEN box.
The question arises as to why somatic cells should switch
from degradation mediated by APC/C
Cdc20 to APC/C
Cdh1 in
anaphase. Clearly this is not required for exit from mitosis
itself because degradation in embryonic cell cycles, such as
those of Drosophila and Xenopus, is mediated solely by
Cdc20. It could be that APC/C
Cdh1 is required because there
are some late mitotic regulators that are only present in so-
matic cells that cannot be recognized by APC/C
Cdc20. Alter-
natively, there may be some proteins that must be degraded
in somatic cells but not in embryonic cells. Such proteins
could include the regulators or components of the prerepli-
cation complex because one of the major differences be-
tween somatic cell cycles and embryonic cell cycles is that
somatic cells have an interval (G1) between mitosis and the
next round of DNA replication. During G1 phase, somatic
cells integrate intra- and extracellular signals before commit-
ment to another round of DNA replication rather than the
alternative fates of differentiation or quiescence. Thus, it
may be important for somatic cells to ensure that compo-
nents of the DNA replication machinery are not present un-
til they commit to another round of proliferation. Equally, it
is becoming clear that once somatic cells exit the cell cycle
and differentiate the APC/C plays an important part in the
physiology of postmitotic cells (Gieffers et al., 1999) where
it must recognize substrates that are very different from
those found in proliferating cells. However, this does not
provide an answer to why Cdc20 itself should become a tar-
get for degradation upon exit from mitosis in somatic cells.
Lastly, our observation that a second cleavage furrow can
form between the separating sister chromatids after all the
chromosomes have moved to one pole indicates that the cy-
tokinesis furrow can be very rapidly established, apparently
by unseparated chromosomes. It will be interesting to deter-
mine which of the chromosomal passenger proteins impli-
cated in cytokinesis are carried toward one spindle pole by
the unseparated chromosomes and whether any are left be-
hind at the first cleavage furrow.
Materials and methods
Cell culture and synchronization
HeLa cells and PtK1 cells were cultured and synchronized as described
previously (Clute and Pines, 1999).
Construction of cDNA plasmids
Fusion proteins and point mutations were constructed by PCR using VENT
polymerase (New England Biolabs, Inc.), cloned in the appropriate vectors,
and confirmed by automated sequencing. Wild-type and mutant securin
constructs were linked at their COOH terminus via a RDPPVAT linker to
YFP or CFP in pEYFP/N1 or pECFP/N1 (CLONTECH Laboratories, Inc.). For
the in vitro ubiquitination and transfections experiments, the securin con-
structs were subcloned into pCDNA3 (Invitrogen). The D-box of securin
from R
61 to N
68 was deleted to generate the securin D-box deletion mutant,
the sequence K
9 E
10 N
11 was replaced by three alanines to obtain the KEN
box mutant, and to generate the D-box/KEN box double mutant these two
mutations were combined. To generate a point mutation in the D-box, R
61
was replaced by alanine. pCMX/cyclin B1–YFP has been described previ-
ously (Hagting et al., 1999.) To generate cyclin B1–CFP, cyclin B1 was
linked by its COOH terminus to CFP via a linker with the sequence LERD-
PPVAT using pECFP/N1. R
42 of cyclin B1–CFP was replaced by an alanine
to generate a nondegradable cyclin B1–CFP. R
42A–B1–GFP has been de-
scribed previously (Clute and Pines, 1999). pEF-Bub1 dominant negative
(NH2-terminal fragment of mouse Bub1 [N334 was a gift from Stephan Ge-
ley and Tim Hunt, Cancer Research UK]) (Geley et al., 2001). All plasmids
were resuspended in 10 mM Tris, pH 8.0, for microinjection (YFP con-
structs at 0.01 mg/ml, the CFP constructs at 0.05 mg/ml, and Bub1 DN at
0.1 mg/ml). Maps of all constructs and sequences used in this study are
available on request.
Immunofluorescence
HeLa cells were seeded onto metasilicate-coated coverslips and then fixed
and stained using paraformaldehyde/Triton as described (Pines, 1997). The
antisecurin primary antibody (a gift from Hui Zou, Harvard Medical1136 The Journal of Cell Biology | Volume 157, Number 7, 2002
School, Cambridge, MA) was diluted 1:1,000 in 3% BSA/PBS, and washes
were performed with PBS. Anti-CREST serum (a gift from Dr. Bill Earn-
shaw, University of Edinburgh, Edinburgh, UK) was used at 1:20,000, and
anti–phospho-histone H3 Serine 28 (a gift from Dr. Inagaki, Aichi Cancer
Center Research Institute, Nagoya, Japan) was used at 1:100. Secondary
antibodies linked to Texas red (1:200; Jackson ImmunoResearch Laborato-
ries) or Alexa dyes 594 or 647 (1:400; Molecular Probes) or Cy5 (1:200;
Amersham Pharmacia Biotech) were diluted as indicated. Coverslips were
mounted in 0.1% 1,4-phenylenediamine, 90% glycerol in PBS (pH 9.0).
Cells were analyzed by confocal laser scanning microscopy.
Coimmunoprecipitation
HeLa cells grown to  60% confluency were transiently transfected with
pcDNA3-myc securin and with pcDNA3-myc securin–YFP constructs. For
transfection, LipofectAMINE PLUS™ (GIBCO BRL) was used according to
the manufacturer’s instructions. After 24 h of transfection, cells were treated
with nocodazole for 18 h at a final concentration of 330 nM. Subsequently,
cells were harvested, and cell extracts were prepared as described previ-
ously (Waizenegger et al., 2000). 30  l of affi-prep protein A beads (Bio-Rad
Laboratories, Inc.) coupled with 30  g affinity purified rabbit antihseparase
antibodies or with 30  g affinity purified rabbit anti-CDC27 antibodies (a gift
from Christian Gieffers, Research Institute of Molecular Pathology) were
used for immunoprecipitation. 1.4 mg of a low speed supernatant of cell ex-
tracts was used for the immunoprecipitation. Proteins were allowed to bind
to the antibodies for 3 h 45 min at 4 C. Beads were washed several times
with 0.5 M NaCl in TBS supplemented with 0.5% Tween 20 and 1 mM
DTT. Immunoprecipitates were eluted from beads by the addition of 40  l of
sample buffer. Immunoprecipitates were immunoblotted with mouse mono-
clonal antibody against hseparase (7A6; 1:1,000 diluted) with mouse mono-
clonal antibody against hsecurin (a gift from Claus Sørensen and Jiri Lukas,
Danish Cancer Center, Copenhagen, Denmark; 1:500 diluted) and with
mouse monoclonal antibodies against GFP (1814460; Roche).
Microinjection and time-lapse imaging and analysis
Cells were injected and analyzed by time-lapse DIC fluorescence micros-
copy as described previously (Clute and Pines, 1999; Furuno et al., 1999).
For comparative quantitative analyses, all parameters were fixed; a fluores-
cence exposure time of 250 ms and a 40  oil objective with a numerical
aperture of 1.0 were used. Images were saved in IP Lab Spectrum format as
unsigned 16 data using a reference look up table with a preset linear pixel
intensity scale. IP Lab Spectrum (Scanalytics) or a modified version of Im-
age J software (NIH) was used to quantify the amount of fluorescence as
described previously (Clute and Pines, 1999; Furuno et al., 1999). DIC im-
ages were used to determine mitotic phases. Images were converted to
PICT format and exported to Adobe
® PhotoShop.
In vitro ubiquitination
[
35S]methionine- and [
35S]cysteine-labeled wild-type or mutated securin
and securin–YFP were prepared by coupled transcription-translation reac-
tions in rabbit reticulocyte lysate (Promega). To obtain APC/C
CDH1, APC/C
was immunoprecipitated from Xenopus egg interphase extracts using anti-
APC3/CDC27 antibody beads. To obtain mitotic APC/C appropriate for ac-
tivation by CDC20, interphase egg extracts were driven into mitosis by ad-
dition of nondegradable sea urchin cyclin B  90 and used for immunopre-
cipitation with anti-APC3 antibody beads. The beads were subsequently
washed three times with buffer XB (10 mM Hepes-KOH, pH 7.7, 100 mM
KCl, 1 mM MgCl2, 0.1 mM CaCl2) supplemented with 0.2  M okadaic
acid and incubated with 100 ng recombinant purified CDH1 or CDC20
(Kramer et al., 2000) in buffer XB plus okadaic acid for 12 min at room
temperature. After two more washing steps in XB plus okadaic acid, 5  l
beads were used in ubiquitination reactions containing purified E1 (80  g/
ml), UBC4 and UBCx (50  g/ml each), ubiquitin (1.25 mg/ml), ATP regen-
erating system (7.5 mM creatine phosphate, 1 mM ATP, 1 mM MgCl2, 0.1
mM EGTA, 30 U/ml rabbit creatine phosphokinase type I [Sigma-Aldrich]),
and 2  l in vitro–translated substrate in a final volume of 15  l in buffer
QA (10 mM Hepes-KOH, pH 7.7, 100 mM KCl, 1 mM MgCl2, 0.1 mM
CaCl2, 1 mM DTT). One half of the reaction was removed immediately
and mixed with SDS-PAGE sample buffer, whereas the other half was incu-
bated for 30 min at 25 C on a shaker before addition of sample buffer. The
reaction was analyzed by SDS-PAGE and phosphorimaging. The ratio of
polyubiquitinated substrate to total substrate was calculated after quantifi-
cation using the ImageQuant software (Molecular Dynamics).
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